zalcitabine has been researched along with Abnormalities, Autosome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhat, B; Carroll, SS; Cook, PD; Eldrup, AB; Galloway, SM; Hilliard, C; MacCoss, M; Olsen, DB; Prakash, TP; Prhavc, M; Stahlhut, MW; Tomassini, JE | 1 |
Antoccia, A; Berardinelli, F; Cherubini, R; De Nadal, V; Fioramonti, M; Gerardi, S; Leone, S; Moreno, S; Nardacci, R; Nieri, D; Tanzarella, C | 1 |
Clements, J; Clive, D; Elliott, BM; Green, M; Honma, M; Müller, L; San, RH; Shimada, H; Sofuni, T; Thybaud, V; Wilcox, P | 1 |
3 other study(ies) available for zalcitabine and Abnormalities, Autosome
Article | Year |
---|---|
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replication.
Topics: Animals; Cell Line, Tumor; CHO Cells; Chromosome Aberrations; Cricetinae; Cricetulus; Cytidine; Cytidine Monophosphate; Hepacivirus; Humans; Organophosphates; Prodrugs; RNA-Dependent RNA Polymerase; RNA, Viral; Tritium; Viral Nonstructural Proteins; Virus Replication | 2005 |
Radiation response of chemically derived mitochondrial DNA-deficient AG01522 human primary fibroblasts.
Topics: Antimetabolites; Cell Survival; Cells, Cultured; Chromosome Aberrations; DNA Damage; DNA Repair; DNA, Mitochondrial; Fibroblasts; Humans; In Situ Hybridization, Fluorescence; Linear Energy Transfer; Membrane Potential, Mitochondrial; Mitochondria; Reactive Oxygen Species; Telomere; X-Rays; Zalcitabine | 2013 |
Mouse lymphoma workshop: Victoria, British Columbia, Canada, March 27, 1996 protocol issues regarding the use of the Microwell Method of the Mouse Lymphoma Assay.
Topics: Adenosine; Animals; Cell Division; Chromosome Aberrations; Dose-Response Relationship, Drug; Lymphoma; Mice; Mutagenicity Tests; Mutation; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Software; Thymidine; Time Factors; Tumor Cells, Cultured; Zalcitabine | 1997 |